Sign up to save your podcasts
Or
Share Ensysce Biosciences Discusses TAAP and MPAR® Applications and OncoZenge Partnership with The Stock Day Podcast
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Ensysce Biosciences Discusses TAAP and MPAR® Applications and OncoZenge Partnership with The Stock Day Podcast
The Stock Day Podcast welcomed Ensysce Biosciences (Nasdaq:ENSC)(“the Company”), a clinical-stage company using its proprietary technology platforms to develop safer prescription drugs. CEO of the Company, Dr. Lynn Kirkpatrick, joined Stock Day host Matthew Dunehoo.
Advertising Inquiries: https://redcircle.com/brands
Privacy & Opt-Out: https://redcircle.com/privacy
View all episodes
By Stock Day Media
4.4
3131 ratings
The Stock Day Podcast welcomed Ensysce Biosciences (Nasdaq:ENSC)(“the Company”), a clinical-stage company using its proprietary technology platforms to develop safer prescription drugs. CEO of the Company, Dr. Lynn Kirkpatrick, joined Stock Day host Matthew Dunehoo.
Advertising Inquiries: https://redcircle.com/brands
Privacy & Opt-Out: https://redcircle.com/privacy